XML 15 R119.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Financial Information for the Company and Its Subsidiaries - Summary of Condensed Consolidating Statement of Cash Flows (Detail) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Operating activities:          
Net income (loss)     $ 110,122 $ (175,486) $ 199,589
Adjustments to reconcile net (loss) income to net cash (used in) provided by continuing operating activities:          
Depreciation and amortization     164,044 158,832 143,010
Amortization of debt issuance costs     11,987 10,456 9,855
Equity-based compensation expense     17,307 22,001 23,467
Deferred income taxes     1,780 (9,714) 31,372
Debt extinguishment costs       1,815 810
Legal settlements expense   $ 22,100   22,076  
Loss on impairment $ 54,400 337,900 54,386 337,889  
Other     4,035 12,371 11,412
Change in operating assets and liabilities, net of effect of acquisitions:          
Accounts receivable, net     (19,060) (16,821) (28,570)
Other current assets     (1,344) 13,864 20,808
Other assets     (73) 2,762 (3,176)
Accounts payable and other accrued liabilities     (21,354) 26,054 (10,113)
Accrued salaries and benefits     7,820 15,748 (8,988)
Other liabilities     3,254 (5,219) 11,794
Net cash provided by continuing operating activities     332,904 416,628 401,270
Net cash used in discontinued operating activities       (2,548) (1,693)
Net cash provided by operating activities     332,904 414,080 399,577
Investing activities:          
Cash paid for acquisitions, net of cash acquired     (45,677)   (18,191)
Cash paid for capital expenditures     (284,682) (341,462) (274,177)
Cash paid for real estate acquisitions     (7,618) (18,383) (41,057)
Settlement of foreign currency derivatives     105,008    
Proceeds from sale of property and equipment     18,076 8,248 5,252
Other     13,752 (9,367) (8,353)
Net cash used in investing activities     (201,141) (360,964) (336,526)
Financing activities:          
Borrowings on revolving credit facility     76,573    
Principal payments on revolving credit facility     (76,573)    
Principal payments on long-term debt     (52,984) (39,738) (57,305)
Repayment of long-term debt       (21,920)  
Common stock withheld for minimum statutory taxes, net     (1,649) (3,407) (3,455)
Distributions to noncontrolling interests     (154)    
Other     (6,840) (2,265) 686
Net cash used in financing activities     (61,627) (67,330) (60,074)
Effect of exchange rate changes on cash     3,546 (2,566) 7,250
Net increase (decrease) in cash and cash equivalents     73,682 (16,780) 10,227
Cash and cash equivalents at beginning of the period     50,510 67,290 57,063
Cash and cash equivalents at end of the period 124,192 50,510 124,192 50,510 67,290
Parent [Member]          
Operating activities:          
Net income (loss)     110,122 (175,486) 199,589
Adjustments to reconcile net (loss) income to net cash (used in) provided by continuing operating activities:          
Equity in earnings of subsidiaries     (174,216) 98,669 (259,282)
Amortization of debt issuance costs     11,987 10,825 10,270
Equity-based compensation expense     17,307 22,001 23,467
Deferred income taxes     441 529 1,236
Debt extinguishment costs       940 810
Other     1,814 6,981 4,189
Change in operating assets and liabilities, net of effect of acquisitions:          
Other assets     3,929 4,596 24,549
Net cash provided by continuing operating activities     (28,616) (30,945) 4,828
Net cash provided by operating activities     (28,616) (30,945) 4,828
Investing activities:          
Settlement of foreign currency derivatives     105,008    
Net cash used in investing activities     105,008    
Financing activities:          
Borrowings on revolving credit facility     76,573    
Principal payments on revolving credit facility     (76,573)    
Principal payments on long-term debt     (52,984) (39,738) (57,050)
Common stock withheld for minimum statutory taxes, net     (1,649) (3,407) (3,455)
Other     (2,375) (1,742) (539)
Cash provided by (used in) intercompany activity     (19,384) 75,832 56,216
Net cash used in financing activities     (76,392) 30,945 (4,828)
Combined Subsidiary Guarantors [Member]          
Operating activities:          
Net income (loss)     124,159 151,659 159,462
Adjustments to reconcile net (loss) income to net cash (used in) provided by continuing operating activities:          
Depreciation and amortization     81,105 74,341 66,482
Deferred income taxes     86 (8,795) 28,882
Legal settlements expense       22,076  
Loss on impairment     27,217    
Other     2,100 5,457 2,498
Change in operating assets and liabilities, net of effect of acquisitions:          
Accounts receivable, net     (13,380) (17,328) (21,791)
Other current assets     776 14,881 (6,429)
Other assets     (2,501) 118 (3,277)
Accounts payable and other accrued liabilities     (5,391) 15,743 4,909
Accrued salaries and benefits     4,283 15,094 (3,974)
Other liabilities     15,110 3,014 8,794
Net cash provided by continuing operating activities     233,564 276,260 235,556
Net cash used in discontinued operating activities       (2,548) (1,693)
Net cash provided by operating activities     233,564 273,712 233,863
Investing activities:          
Cash paid for acquisitions, net of cash acquired     (45,677)    
Cash paid for capital expenditures     (188,161) (210,023) (161,312)
Cash paid for real estate acquisitions     (7,618) (14,096) (37,047)
Proceeds from sale of property and equipment     11,765 5,168 2,415
Other     13,752 (9,367) (10,359)
Net cash used in investing activities     (215,939) (228,318) (206,303)
Financing activities:          
Principal payments on long-term debt       (169) (14,250)
Other     (1,993) 2,094 1,225
Cash provided by (used in) intercompany activity     50,840 (61,708) 16,644
Net cash used in financing activities     48,847 (59,783) 3,619
Net increase (decrease) in cash and cash equivalents     66,472 (14,389) 31,179
Cash and cash equivalents at beginning of the period     32,471 46,860 15,681
Cash and cash equivalents at end of the period 98,943 32,471 98,943 32,471 46,860
Combined Non-Guarantors [Member]          
Operating activities:          
Net income (loss)     50,057 (250,328) 99,820
Adjustments to reconcile net (loss) income to net cash (used in) provided by continuing operating activities:          
Depreciation and amortization     82,939 84,491 76,528
Amortization of debt issuance costs       (369) (415)
Deferred income taxes     1,253 (1,448) 1,254
Debt extinguishment costs       875  
Loss on impairment     27,169 337,889  
Other     121 (67) 4,725
Change in operating assets and liabilities, net of effect of acquisitions:          
Accounts receivable, net     (5,680) 507 (6,779)
Other current assets     (2,120) (1,017) 27,237
Other assets     2,428 2,644 101
Accounts payable and other accrued liabilities     (15,963) 10,311 (15,022)
Accrued salaries and benefits     3,537 654 (5,014)
Other liabilities     (11,856) (8,233) 3,000
Net cash provided by continuing operating activities     131,885 175,909 185,435
Net cash provided by operating activities     131,885 175,909 185,435
Investing activities:          
Cash paid for acquisitions, net of cash acquired         (18,191)
Cash paid for capital expenditures     (96,521) (131,439) (112,865)
Cash paid for real estate acquisitions       (4,287) (4,010)
Proceeds from sale of property and equipment     6,311 3,080 2,837
Other         2,006
Net cash used in investing activities     (90,210) (132,646) (130,223)
Financing activities:          
Principal payments on long-term debt     (3,929) (4,427) (10,554)
Repayment of long-term debt       (21,920)  
Distributions to noncontrolling interests     (154)    
Other     (2,472) (2,617)  
Cash provided by (used in) intercompany activity     (31,456) (14,124) (72,860)
Net cash used in financing activities     (38,011) (43,088) (83,414)
Effect of exchange rate changes on cash     3,546 (2,566) 7,250
Net increase (decrease) in cash and cash equivalents     7,210 (2,391) (20,952)
Cash and cash equivalents at beginning of the period     18,039 20,430 41,382
Cash and cash equivalents at end of the period $ 25,249 $ 18,039 25,249 18,039 20,430
Consolidating Adjustments [Member]          
Operating activities:          
Net income (loss)     (174,216) 98,669 (259,282)
Adjustments to reconcile net (loss) income to net cash (used in) provided by continuing operating activities:          
Equity in earnings of subsidiaries     174,216 (98,669) 259,282
Change in operating assets and liabilities, net of effect of acquisitions:          
Other assets     (3,929) (4,596) (24,549)
Net cash provided by continuing operating activities     (3,929) (4,596) (24,549)
Net cash provided by operating activities     (3,929) (4,596) (24,549)
Financing activities:          
Principal payments on long-term debt     3,929 4,596 24,549
Net cash used in financing activities     $ 3,929 $ 4,596 $ 24,549